Article
Celltrion launches biosimilar of AbbVie's blockbuster drug Humira in US
Rating:
0.0
Views:
75
Likes:
1
Library:
1
South Korea's Celltrion Healthcare has launched a copycat version to AbbVie Inc's Humira at about a 5% discount, adding to the growing competition for the blockbuster rheumatoid arthritis drug in the U.S.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value